跳到主要內容

Patou Gary 的 Form 4/A 修正申報

修正

Xenon Pharmaceuticals Inc.XENE,2023/12/15 申報

申報編號
0000950170-23-070912
申報時間
2023/12/15
交易日
2023/12/14
申報延遲
1 天
10b5-1 計畫
沒有勾選
原始申報日
2023/12/15

這份申報列了 1 筆非衍生性交易。沿用原件裡沒有重述的 12 筆交易。公開市場賣出合計 $75.9 萬。交易後 1 天申報。

這份修正申報重述了 0000950170-23-070841(2023/12/15 申報)的一部分,沒有重述的交易仍然有效,列在下面。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Patou GaryCIK 0001283535董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2023/12/14Common SharesS賣出處分−7,598$41.05F2−$311,897.94,902間接

沿用原件的交易

這份修正申報只重述了原件的一部分。原件其他的交易仍然有效,網站的交易表把它們算在這份修正申報底下。

來自 0000950170-23-070841(2023/12/15 申報)。

非衍生性證券(表 I)

沿用 0000950170-23-070841 的非衍生性證券交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2023/12/13Common SharesM行使選擇權取得+6,378$9.85F2+$62,823.329,951直接
2023/12/13Common SharesF扣股繳稅處分−1,278$39.68F3−$50,711.0428,673直接
2023/12/13Common SharesS賣出處分−5,100$38.94F4−$198,59423,573直接
2023/12/13Common SharesM行使選擇權取得+2,880$9.85F2+$28,36826,453直接
2023/12/13Common SharesF扣股繳稅處分−577$39.68F3−$22,895.3625,876直接
2023/12/13Common SharesS賣出處分−2,303$39.10F5−$90,047.323,573直接
2023/12/13Common SharesM行使選擇權取得+5,144$9.00+$46,29628,717直接
2023/12/13Common SharesF扣股繳稅處分−1,167$39.68F3−$46,306.5627,550直接
2023/12/13Common SharesS賣出處分−3,977$39.84−$158,443.6823,573直接

衍生性證券(表 II)

沿用 0000950170-23-070841 的衍生性證券交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2023/12/13Common SharesM行使選擇權處分−6,378$0.00$00直接
2023/12/13Common SharesM行使選擇權處分−2,800$0.00$00直接
2023/12/13Common SharesM行使選擇權處分−5,144$0.00$00直接

原件的附註

這幾筆交易的價格在原件上引用的附註。

F2

The exercise price was converted to U.S. dollars from $10.78 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

表 I 有 2 筆交易的價格引用這則附註。

F3

Represents the closing price of the Company's common shares in U.S. dollars on December 12, 2023, which was converted to a Canadian dollar amount for purposes of net settlement calculations.

表 I 有 3 筆交易的價格引用這則附註。

F4

The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.81 to $39.13, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

表 I 有 1 筆交易的價格引用這則附註。

F5

The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $39.04 to $39.16, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

表 I 有 1 筆交易的價格引用這則附註。

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

Pursuant to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023, the Reporting Person is permitted to transfer up to 22,000 common shares beneficially owned prior to November 29, 2023 or received upon the exercise of an option to purchase common shares during the lock-up period.

F2

The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.06, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

表 I 有 1 筆交易的價格引用這則附註。

F3

By Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou.

備註

This amendment corrects the transaction date that was inaccurately reported on the original Form 4 due to a clerical error.

看 SEC EDGAR 上的完整原文 (在新分頁開啟)